TLPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
TALPHERA, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.08+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $81.57M
- P/E (TTM)
- –
- Dividend yield
- –
Talphera statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Talphera | Industry median |
|---|---|---|
| Market Cap | $56.06M | $197.05M |
| Enterprise Value | $38.98M | $106.56M |
| PS Ratio | 56058.30 | 3.93 |
| PB Ratio | 3.89 | 2.14 |
| P/TBV Ratio | 10.03 | 2.46 |
Enterprise value
| Measure | Talphera | Industry median |
|---|---|---|
| EV / Sales | 38982.30 | 2.69 |
Income (trailing twelve months)
| Measure | Talphera | Industry median |
|---|---|---|
| Revenue | $1.00K | $57.94M |
| Operating Income | -$14.75M | -$21.44M |
| Net Income | -$15.08M | -$22.46M |
| EBITDA | -$14.75M | -$16.91M |
| EPS (Diluted) | -$0.27 | -$0.83 |
Margins
| Measure | Talphera | Industry median |
|---|---|---|
| Operating Margin | -1474700.0% | -44.5% |
| Profit Margin | -1507600.0% | -39.2% |
| EBITDA Margin | -1474700.0% | -31.3% |
Returns
| Measure | Talphera | Industry median |
|---|---|---|
| Return on Equity (ROE) | -143.4% | -53.1% |
| Return on Assets (ROA) | -69.6% | -41.0% |
| Return on Capital Employed (ROCE) | -65.2% | -37.8% |
Growth
| Measure | Talphera | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -96.3% | 6.01% |
| Revenue Growth (5Y CAGR) | -65.1% | 6.42% |
Balance sheet
| Measure | Talphera | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $17.08M | $62.42M |
| Net Cash (Debt) | $17.08M | $15.68M |
| Net Cash Per Share | $0.33 | $0.65 |
| Equity (Book Value) | $14.41M | $48.79M |
| Book Value Per Share | $0.28 | $1.36 |
| Tangible Book Value | $5.59M | $23.06M |
| Working Capital | $13.80M | $75.77M |
Financial position
| Measure | Talphera | Industry median |
|---|---|---|
| Current Ratio | 4.29 | 3.30 |
| Quick Ratio | 4.08 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Talphera | Industry median |
|---|---|---|
| Operating Cash Flow | -$12.27M | -$12.35M |
Efficiency
| Measure | Talphera | Industry median |
|---|---|---|
| Asset Turnover | 0.00 | 0.38 |
| Revenue Per Employee | $83 | $398.96K |
| Profits Per Employee | -$1.26M | -$732.08K |
| Employee Count | 12 | 73 |
Dividends and yields
| Measure | Talphera | Industry median |
|---|---|---|
| Earnings Yield | -26.9% | -21.2% |
Shares
| Measure | Talphera | Industry median |
|---|---|---|
| Shares Outstanding | 51,905,800 | 59,128,900 |
| Shares Change (YoY) | 124.3% | 11.1% |
| Shares Change (QoQ) | 3.71% | 0.54% |
| Float | 27,606,400 | 48,744,500 |
| Shares Held by Insiders | 46.8% | 11.8% |
| Shares Held by Institutions | 54.4% | 59.4% |
Scores
| Measure | Talphera | Industry median |
|---|---|---|
| Altman Z-Score | -23.47 | 0.10 |
| Piotroski F-Score | 5 | 4 |
Calculated by StockData from Talphera's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.